Can chemo before surgery stop prostate cancer from spreading?
NCT ID NCT03258320
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving chemotherapy before surgery can help control high-risk prostate cancer and prevent it from coming back or spreading. About 300 men aged 40 to 75 will receive one of four chemo drugs followed by prostate removal. The goal is to see if this approach improves 5-year survival without the cancer returning.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER PATIENTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Qilu Hospital of Shandong University
RECRUITINGQingdao, Shandong, 266035, China
-
Zhongshan Hospital
RECRUITINGShanghai, 200032, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single radiation type spare prostate cancer patients from extra side effects?
- Can a Triple-Drug cocktail before surgery curb prostate Cancer's return?
- AI chatbot aims to demystify prostate cancer radiation — a trial puts it to the test
- Exercise may counteract side effects of prostate cancer hormone therapy
- Combination therapy aims to wipe out High-Risk prostate cancer before surgery
- Can a digital guide boost genetic testing in prostate cancer survivors?